Rate your conversation

🙁 😐 😃 🤩

Thanks for the feedback!

Skip to main content

For questions about financial assistance,
call 1-844-DUPIXENT, option 1 or
click to learn more

BACK TO DUPIXENT.COM
ESPAÑOL
Prescribing &
Patient Information
- PATIENT INFORMATION
- Patient Information - English
- Patient Information - Spanish
- PRESCRIBING INFORMATION
- Prescribing Information - English
- Prescribing Information - Spanish
- PRE-FILLED SYRINGE INSTRUCTIONS FOR USE
- 200 mg Syringe - English
- 200 mg Syringe - Spanish
- 300 mg Syringe - English
- 300 mg Syringe - Spanish
- PRE-FILLED PEN INSTRUCTIONS FOR USE
- 200 mg Pen - English
- 200 mg Pen - Spanish
- 300 mg Pen - English
- 300 mg Pen - Spanish
For Healthcare
Professionals
Copay
Offer
Patient
Brochure
FOR U.S. RESIDENTS ONLY

Get Email Updates

Get Email Updates
HOME
What is
Asthma?
About
DUPIXENT
PATIENT SUPPORT,
COST & SAVINGS
Taking
Dupixent
Resources
CONNECT
WITH REAL
PATIENTS
- Patient Stories
- Connect With a Mentor
ESPAÑOL
For Healthcare Professionals
Copay Offer
Patient Brochure

This page will redirect to [] on the public side

Important Safety Information
and Indication

Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®.

Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you:

have a parasitic (helminth) infection
are scheduled to receive any vaccinations. You should not receive a "live vaccine" right before and during treatment with DUPIXENT.
are pregnant or plan to become pregnant. It is not known whether DUPIXENT will harm your unborn baby.
- A pregnancy registry for women who take DUPIXENT during pregnancy collects information about the health of you and your baby. To enroll or get more information call 1-877-311-8972 or go to https://mothertobaby.org/ongoing-study/dupixent/.
are breastfeeding or plan to breastfeed. It is not known whether DUPIXENT passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines or use an asthma medicine. Do not change or stop your other medicines, including corticosteroid medicine or other asthma medicine, without talking to your healthcare provider. This may cause other symptoms that were controlled by those medicines to come back.

DUPIXENT can cause serious side effects, including:

Allergic reactions. DUPIXENT can cause allergic reactions, including skin reactions, that can sometimes be severe. Stop using DUPIXENT and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms: breathing problems or wheezing, swelling of the face, lips, mouth, tongue, or throat, fainting, dizziness, feeling lightheaded, fast pulse, fever, hives, skin rash, including rash that looks like a bullseye or painful red or blue bumps under the skin, general ill feeling, itching, swollen lymph nodes, nausea or vomiting, joint pain, or cramps in your stomach area.
Inflammation of your blood vessels. Rarely, this can happen in people with asthma who receive DUPIXENT. This may happen in people who also take a steroid medicine by mouth that is being stopped or the dose is being lowered. Tell your healthcare provider right away if you get: rash, chest pain, worsening shortness of breath, brown or dark colored urine, persistent fever, or a feeling of pins and needles or numbness of your arms or legs.
Psoriasis. This can happen in people with asthma who receive DUPIXENT. Tell your healthcare provider about any new skin symptoms. Your healthcare provider may send you to a dermatologist for an examination if needed.
Joint aches and pain. Some people who use DUPIXENT have had trouble walking or moving due to their joint symptoms, and in some cases needed to be hospitalized. Tell your healthcare provider about any new or worsening joint symptoms. Your healthcare provider may stop DUPIXENT if you develop joint symptoms.

The most common side effects in patients with asthma include injection site reactions, high count of a certain white blood cell (eosinophilia), pain in the throat (oropharyngeal pain), and parasitic (helminth) infections.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of DUPIXENT. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Use DUPIXENT exactly as prescribed by your healthcare provider. It’s an injection given under the skin (subcutaneous injection). Your healthcare provider will decide if you or your caregiver can inject DUPIXENT. Do not try to prepare and inject DUPIXENT until you or your caregiver have been trained by your healthcare provider. In children 12 years of age and older, it’s recommended DUPIXENT be administered by or under supervision of an adult. In children 6 to less than 12 years of age, DUPIXENT should be given by a caregiver.

Please see accompanying full Prescribing Information including Patient Information.

Indication

DUPIXENT is a prescription medicine used with other asthma medicines for the maintenance treatment of moderate-to-severe eosinophilic or oral steroid dependent asthma in adults and children 6 years of age and older whose asthma is not controlled with their current asthma medicines. DUPIXENT helps prevent severe asthma attacks (exacerbations) and can improve your breathing. DUPIXENT may also help reduce the amount of oral corticosteroids you need while preventing severe asthma attacks and improving your breathing. DUPIXENT is not used to relieve sudden breathing problems and will not replace an inhaled rescue medicine. It is not known if DUPIXENT is safe and effective in children with asthma under 6 years of age.

Site Map
Legal Disclaimer Information

Questions or comments?
Contact Sanofi US or Regeneron Pharmaceuticals, Inc. or call 1-844-387-4936
to contact DUPIXENT MyWay®.

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
DUPIXENT and DUPIXENT MyWay are registered trademarks of Sanofi or an affiliate.

Sanofi US is hosting this website on behalf of Sanofi and Regeneron Pharmaceuticals, Inc.

Sanofi and Regeneron are industry partners, who are committed to handling personal data in ways that respect your privacy. Both companies may independently process your personal data to manage patient support programs and product marketing campaigns. Please refer to Regeneron’s Privacy Notice and Consumer Health Data Privacy Policy and Sanofi’s Privacy Policy and Consumer Health Data Privacy Policy and Cookies Policy for more information regarding processing of your personal data.

This DUPIXENT® (dupilumab) website is for U.S. healthcare professionals only. Click “continue” only if you are a U.S. healthcare professional.

US-DAS-1231(1)

Are you sure you want to leave?

Please note: By clicking on this link, you will be leaving this Sanofi-hosted US website and going to another, entirely independent website. Sanofi US and Regeneron provide these links as a service to their website visitors and users; however, they take no responsibility for the information on any website but their own.

Enter your email address and we will send you your requested resource.

Email Address Please enter a valid email address.

Success!

Your email is on its way. Be sure to check your inbox.

Enter your email address and we will send you your personalized guide.